By addressing hormone imbalances and underlying health issues, these treatments pave the way for a transformative journey toward better health
Novo Nordisk agonist shows strong trial results as MASH cases rise among US adults For the first time, a GLP-1 therapy has been cleared to treat metabolic dysfunction-associated steatohepatitis (MASH), after the US Food and Drug Administration (FDA) granted accelerated approval to Novo Nordisks weight-loss drug Wegovy
JUpiter ICy moons Explorer: an ESA mission to orbit Ganymede and to characterise the Jupiter system
Women of childbearing potential should use effective contraception during therapy
While most of the alleged concerns are just distractions with little evidentiary basis, some may reflect more legitimate drawbacks to these medications
Precursors to Glutathione: Certain supplements, such as N-acetylcysteine (NAC) and alpha-lipoic acid, are glutathione precursors